Skip to content

Observation of Ama in amavata patients, tail bindu pareeksha and stool culture

An observational case control study on assessment of ama in the patients of amavata(Rheumatoid arthritis),tail bindu pareeksha of urine and stool culture

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/02/031193
Enrollment
60
Registered
2021-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M069- Rheumatoid arthritis, unspecified

Interventions

None listed

Sponsors

All India institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of Amavata having any four of the cardinal features of Amavata i.e.Gaurav, Sandhishula, Sandhishotha, SandhiStabdhata, Sparshaasahyata, agnidaurbalya will be included for the present study from the patients coming to the IPD of AIIA. Willing to participate in the study

Exclusion criteria

Exclusion criteria: Psychiatric illness, DM, gout, known case of carcinoma, pregnant and lactating mother will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
To Develop a Validate Ama Assessment Scale (AAS) for the patients of Amavata based on the parameters mentioned in Ayurveda texts.Timepoint: 1 year

Secondary

MeasureTime frame
1. To record and analyse the values of some biochemical markers in patients of Amavata and controls in relation to level of Ama. 2.To document the behaviour of Taila bindu pareeksha in early morning urine sample of Amavata patients and healthy controls and analyze it in relation to level of Ama 3.To study the growth of E. coli, Salmonella, Streptococcus pyogenes strains in the Amavata patients and healthy controls and analyse it in relation to level of Ama. Timepoint: 1 year

Countries

India

Contacts

Public ContactDr Anand more

All India institute of Ayurveda

vd.raishalini@gmail.com9389423843

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026